Video Experimental Relacionado
Updated: Jun 21, 2026
11:12
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
Published on: October 17, 2013
Manejo antitrombótico de pacientes con válvulas cardíacas protésicas: evidencia actual y tendencias futuras
Jack C J Sun1, Michael J Davidson, Andre Lamy
1Division of Cardiac Surgery, McMaster University, Hamilton, ON, Canada. sunjc2@mcmaster.ca
Lancet (London, England)
|August 18, 2009
Resumen
Las válvulas cardíacas protésicas mejoran la vida, pero requieren terapia antitrombótica para prevenir los coágulos. Los nuevos avances ofrecen esperanza, especialmente para las naciones en desarrollo que se enfrentan al aumento de la enfermedad valvular cardíaca.
Área de la Ciencia:
- Cardiología Cardiología.
- Ingeniería Biomédica Ingeniería Biomédica.
Sus antecedentes:
- Más de 4 millones de personas en todo el mundo tienen válvulas cardíacas protésicas, con 300.000 implantes al año.
- Las válvulas protésicas mejoran la supervivencia para la enfermedad valvular cardíaca grave.
- La terapia antitrombótica es crucial pero desafiante para los receptores de válvulas.
Objetivo del estudio:
- Revisar las terapias antitrombóticas para pacientes con prótesis de válvulas cardíacas.
- Para discutir el manejo de las complicaciones tromboembólicas.
- Para identificar las necesidades no satisfechas en el manejo de la enfermedad valvular del corazón.
Principales métodos:
- Revisión de la literatura sobre las terapias antitrombóticas.
- Análisis de las tecnologías actuales de válvulas protésicas.
- Evaluación de las tendencias mundiales en la enfermedad valvular del corazón.
Principales resultados:
- La terapia antitrombótica es esencial para prevenir las complicaciones trombóticas.
- Los avances en terapia y tecnología de válvulas están mejorando los resultados de los pacientes.
- Los países en desarrollo representan un área crítica para la intervención debido a la creciente carga de enfermedades.
Conclusiones:
- Las mejores estrategias antitrombóticas y las tecnologías de válvulas benefician a los pacientes en todo el mundo.
- Significativas necesidades insatisfechas persisten, particularmente en las naciones en desarrollo.
- Los esfuerzos futuros deben centrarse en el acceso equitativo a tratamientos avanzados para la enfermedad valvular cardíaca.
Videos de Conceptos Relacionados
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:18Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...